Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes

Supplemental Digital Content is available in the text. Rationale: Genome-wide association studies have identified genetic loci associated with insulin resistance (IR) but pinpointing the causal genes of a risk locus has been challenging. Objective: To identify candidate causal genes for IR, we screened regional and biologically plausible genes (16 in total) near the top 10 IR-loci in risk-relevant cell types, namely preadipocytes and adipocytes. Methods and Results: We generated 16 human Simpson-Golabi-Behmel syndrome preadipocyte knockout lines each with a single IR-gene knocked out by lentivirus-mediated CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system. We evaluated each gene knockout by screening IR-relevant phenotypes in the 3 insulin-sensitizing mechanisms, including adipogenesis, lipid metabolism, and insulin signaling. We performed genetic analyses using data on the genotype-tissue expression portal expression quantitative trait loci database and accelerating medicines partnership type 2 diabetes mellitus Knowledge Portal to evaluate whether candidate genes prioritized by our in vitro studies were expression quantitative trait loci genes in human subcutaneous adipose tissue, and whether expression of these genes is associated with risk of IR, type 2 diabetes mellitus, and cardiovascular diseases. We further validated the functions of 3 new adipose IR genes by overexpression-based phenotypic rescue in the Simpson-Golabi-Behmel syndrome preadipocyte knockout lines. Twelve genes, PPARG, IRS-1, FST, PEPD, PDGFC, MAP3K1, GRB14, ARL15, ANKRD55, RSPO3, COBLL1, and LYPLAL1, showed diverse phenotypes in the 3 insulin-sensitizing mechanisms, and the first 7 of these genes could affect all the 3 mechanisms. Five out of 6 expression quantitative trait loci genes are among the top candidate causal genes and the abnormal expression levels of these genes (IRS-1, GRB14, FST, PEPD, and PDGFC) in human subcutaneous adipose tissue could be associated with increased risk of IR, type 2 diabetes mellitus, and cardiovascular disease. Phenotypic rescue by overexpression of the candidate causal genes (FST, PEPD, and PDGFC) in the Simpson-Golabi-Behmel syndrome preadipocyte knockout lines confirmed their function in adipose IR. Conclusions: Twelve genes showed diverse phenotypes indicating differential roles in insulin sensitization, suggesting mechanisms bridging the association of their genomic loci with IR. We prioritized PPARG, IRS-1, GRB14, MAP3K1, FST, PEPD, and PDGFC as top candidate genes. Our work points to novel roles for FST, PEPD, and PDGFC in adipose tissue, with consequences for cardiometabolic diseases. Visual Overview: An online visual overview is available for this article.

[1]  Anthony J. Payne,et al.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.

[2]  Jussi Taipale,et al.  CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response , 2018, Nature Medicine.

[3]  A. Chen-Plotkin,et al.  The Post-GWAS Era: From Association to Function. , 2018, American journal of human genetics.

[4]  M. Kolonin,et al.  PDGFRα/PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes , 2018, Development.

[5]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[6]  Steve Epstein,et al.  Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease , 2017, Nature Genetics.

[7]  D. Levy,et al.  Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States , 2017, PLoS genetics.

[8]  D. Rahelić,et al.  Insulin and the polycystic ovary syndrome. , 2017, Diabetes research and clinical practice.

[9]  G. Goossens The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function , 2017, Obesity Facts.

[10]  Y. Liao,et al.  ADP-ribosylation factor-like GTPase 15 enhances insulin-induced AKT phosphorylation in the IR/IRS1/AKT pathway by interacting with ASAP2 and regulating PDPK1 activity. , 2017, Biochemical and biophysical research communications.

[11]  Chad A. Cowan,et al.  The NextGen Genetic Association Studies Consortium: A Foray into In Vitro Population Genetics. , 2017, Cell stem cell.

[12]  M. Vasseur-Cognet,et al.  Growth factor receptor binding protein 14 inhibition triggers insulin‐induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma , 2017, Hepatology.

[13]  Allison J. Richard,et al.  Transcriptional Regulation of Adipogenesis. , 2017, Comprehensive Physiology.

[14]  Aiqing He,et al.  Genetic Regulation of Adipose Gene Expression and Cardio-Metabolic Traits. , 2017, American journal of human genetics.

[15]  Andrew D. Johnson,et al.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance , 2016, Nature Genetics.

[16]  M. McCarthy,et al.  Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants , 2016, Diabetes.

[17]  J. Flannick,et al.  Type 2 diabetes: genetic data sharing to advance complex disease research , 2016, Nature Reviews Genetics.

[18]  M. Birnbaum,et al.  Lack of AKT in adipocytes causes severe lipodystrophy , 2016, Molecular metabolism.

[19]  H. Grallert,et al.  Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis , 2016, PloS one.

[20]  N. Patni,et al.  Congenital generalized lipodystrophies—new insights into metabolic dysfunction , 2015, Nature Reviews Endocrinology.

[21]  Sebastian M. Armasu,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2015, Nature Genetics.

[22]  J. L. Mateo,et al.  CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool , 2015, PloS one.

[23]  K. Petersen,et al.  Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes , 2015, Cell.

[24]  Y. Hua,et al.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications. , 2015, Biochimica et biophysica acta.

[25]  Jaana M. Hartikainen,et al.  Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. , 2015, American journal of human genetics.

[26]  M. McCarthy,et al.  Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity , 2014, Diabetes.

[27]  F. Liu,et al.  Tissue‐specific insulin signaling in the regulation of metabolism and aging , 2014, IUBMB life.

[28]  P. Arner,et al.  Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance , 2014, Trends in Endocrinology & Metabolism.

[29]  E. Dermitzakis,et al.  Expression quantitative trait loci: present and future , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[30]  Yuesheng Zhang,et al.  Prolidase Directly Binds and Activates Epidermal Growth Factor Receptor and Stimulates Downstream Signaling* , 2012, The Journal of Biological Chemistry.

[31]  Tanya M. Teslovich,et al.  Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways , 2012, Nature Genetics.

[32]  P. Fischer-Posovszky,et al.  Differential function of Akt1 and Akt2 in human adipocytes , 2012, Molecular and Cellular Endocrinology.

[33]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[34]  C. Glass,et al.  Inflammation and lipid signaling in the etiology of insulin resistance. , 2012, Cell metabolism.

[35]  G. Shulman,et al.  Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. , 2012, Cell metabolism.

[36]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[37]  Tom Misteli,et al.  SnapShot: Chromosome Conformation Capture , 2012, Cell.

[38]  H. Ashida,et al.  Measurement of Glucose Uptake in Cultured Cells , 2011, Current protocols in pharmacology.

[39]  Olle Melander,et al.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.

[40]  O. Erel,et al.  The association of serum prolidase activity with the presence and severity of coronary artery disease , 2008, Coronary artery disease.

[41]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[42]  C. Betsholtz,et al.  A specific requirement for PDGF-C in palate formation and PDGFR-α signaling , 2004, Nature Genetics.

[43]  E. Raines PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[44]  M. Laville,et al.  Increased adipose tissue expression of Grb14 in several models of insulin resistance , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  M. Birnbaum,et al.  Role of Akt/protein kinase B in metabolism , 2002, Trends in Endocrinology & Metabolism.

[46]  Y. Terauchi,et al.  Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation , 2001, Molecular and Cellular Biology.

[47]  C. Laurino,et al.  Role of IRS-1 and SHC activation in 3T3-L1 fibroblasts differentiation. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[48]  Chad A. Cowan,et al.  Humanity in a Dish: Population Genetics with iPSCs. , 2018, Trends in cell biology.

[49]  M. Wabitsch,et al.  Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation , 2001, International Journal of Obesity.